|Articles|September 2, 2005
- Pharmaceutical Technology-09-02-2005
- Volume 29
- Issue 9
FDA Faces Multiple Challenges
Author(s)Jill Wechsler
Commissioner Crawford’s top priority is to restore public confidence in FDA oversight of drug safety and quality.
Advertisement
Articles in this issue
over 20 years ago
Securing the Supply Chain With RFIDover 20 years ago
Applications of Poly(ethylene in Drug Delivery Systems: Part IIover 20 years ago
Analytical Method Equivalency: An Acceptable Analytical Practiceover 20 years ago
September 2005over 20 years ago
Pilots and Partnerships Move RFID Forwardover 20 years ago
Reshaping CMC Development Servicesover 20 years ago
Wash. Rinse. Repeatover 20 years ago
Outsourcing Atrophy: A Cautionary TaleNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
2
Lilly Launches UK Trial of Weight-Loss Drug as US Price Drops
3
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
4
FDA Deploys Agentic AI Capabilities for Agency Staff
5
